HAQ, CDAI, RAPID3, DAS28: Which outcome measure should you use to track progress in patients with rheumatoid arthritis? Here, a brief review of their differences, and the arguments for a new paradigm in disease assessment.
(ACR Pediatrics 2014) How will the hundreds of new genetic biomarkers being found in rheumatology help us to untangle the web of complex diseases? In a brief podcast, a specialist in both rheumatology and genetics discusses recent and future progress.
Autoimmune disorders including rheumatoid arthritis and lupus more than triple the risk of epilepsy in young patients. Early treatment of a rheumatic condition reduces the epilepsy risk, a large study finds.